Recent published data proved that reduction of intracellular beta-catenin levels in AML cell lines and patient samples decreased their rate of proliferation in vitro without affecting cell viability in contrast to what is known for normal human CD34+ progenitor cells [2, 4, 5, 10]. Here, CD34 is linked to acute myeloid leukemia.